X

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Information Technology and Telemedicine Services in Community Oncology Practices
    American Society of Clinical Oncology (ASCO) ; 2023
    In:  JCO Clinical Cancer Informatics , No. 7 ( 2023-08)
    Details
    In: JCO Clinical Cancer Informatics, American Society of Clinical Oncology (ASCO), , No. 7 ( 2023-08)
    Abstract: 3/4 of #ncorp practices used #telemed for research, more use when they have more providers and a survivorship clinic.
    Type of Medium: Online Resource
    ISSN: 2473-4276
    URL: Article
    DOI: 10.1200/CCI.23.00086
    Language: English
    Publisher: American Society of Clinical Oncology (ASCO)
    Publication Date: 2023
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Open Access Request
    Availability (electronic / print)
  • 2
    Online Resource
    Online Resource
    Telemedicine services in community oncology practices.
    American Society of Clinical Oncology (ASCO) ; 2023
    In:  Journal of Clinical Oncology Vol. 41, No. 16_suppl ( 2023-06-01), p. e13678-e13678
    Details
    In: Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 41, No. 16_suppl ( 2023-06-01), p. e13678-e13678
    Abstract: e13678 Background: Telemedicine services have grown tremendously due to the COVID-19 pandemic. We described the use of telemedicine for research purposes at community oncology practices. Methods: We utilized results from the National Cancer Institute Community Oncology Research Program 2017 and 2022 Landscape Surveys, which were designed to understand cancer delivery research capacity in community oncology practices. We used multivariable logistic regression to examine factors associated use of telemedicine for research purpose in 2022, adjusting for region, practice ownership type, and number of oncology providers. Results: Information was available from 504 and 685 discrete practices in 2017 and 2022, respectively. These represent 210 and 259 practice groups; practice groups serving only pediatric patients were excluded. Mean numbers of oncology providers at the practice group level were 18 (IQR 5-21) and 20 (IQR 7-22) in 2017 and 2022, respectively. Over 90% of practice groups reported having outpatient electronic health records and patient portal in both years. In 2022, IT service was available onsite in 71%. In 2017, 31% of practice groups utilized telemedicine for delivery of cancer care and 15% can utilize telemedicine for research purposes. In 2022, telemedicine was used for research purposes in 73% of practice groups. Specifically, telemedicine was used for collection of patient-reported outcomes (54%), delivery of health care interventions (47%), consent (39%), conduct of qualitative interviews (32%), delivery of behavioral interventions (30%), collection of biometric data (e.g., weight, blood pressure) (14%), and collection of neurocognitive testing data (12%). One-third of all practice groups (35%) did not have internet-abled devices available for patients, 53% had them onsite, and 2% had them on site and for patients to take home. On multivariable analysis, a greater number of oncology providers was associated with greater use of telemedicine for research purposes (every 10-unit increase, AOR 1.31, 95% CI 1.04-1.64). Conclusions: From 2017 to 2022, there has been an increased use of telemedicine for research purposes, though its use varies across practices. Bigger practice groups were more likely to use telemedicine for research purpose. Cancer care delivery research that incorporates telemedicine should consider implementing site-specific and standardized resources. [Table: see text]
    Type of Medium: Online Resource
    ISSN: 0732-183X , 1527-7755
    URL: Article
    DOI: 10.1200/JCO.2023.41.16_suppl.e13678
    RVK:
    XA 52760
    RVK:
    XA 10000
    Language: English
    Publisher: American Society of Clinical Oncology (ASCO)
    Publication Date: 2023
    detail.hit.zdb_id: 2005181-5
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Open Access Request
    Availability (electronic / print)
  • 3
    Online Resource
    Online Resource
    Strategies for implementation cancer care delivery studies in a community setting.
    American Society of Clinical Oncology (ASCO) ; 2022
    In:  Journal of Clinical Oncology Vol. 40, No. 16_suppl ( 2022-06-01), p. e13525-e13525
    Details
    In: Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, No. 16_suppl ( 2022-06-01), p. e13525-e13525
    Abstract: e13525 Background: Cancer care delivery Research (CCDR) is a multidisciplinary science that seeks to improve clinical outcomes and patient well-being by intervening on patient, clinician and organizational factors that influence care delivery. Many CCDR protocols also use implementation science to evaluate how best to introduce promising and previously established interventions into everyday care. These types of studies do not typically utilize research and clinic staff in the same ways as traditional treatment trials. One of the main goals of CCDR is for clinics to continue to use the intervention past the time of protocol participation. Even though these studies intend to improve cancer care delivery in the community, it is often difficult for community sites to embrace and prioritize CCDR due to their differences from typical treatment trials. Our recent observatory research highlights one Minority/Underserved (M/U) NCORPs key strategies for successful implementation of a decision aid CCDR trial in a community setting. Methods: HI M/U NCORP identified multiple steps prior to opening and enrolling patients onto a CCDR implementation trial at our community site. Step 1) Identifying an engaged physician and an advanced practice provider (APP) to be champions for the trial at the clinic. 2) Identifying and engaging key clinic staff and ensuring the workflow is feasible in the clinic. Key processes utilized during the entire course of the trial were also identified. 3) Research staff only coordinating and completing purely study related activities and not implementation activities. 4) Engaging other non-traditionally research involved administration staff and department management. 5) Utilizing ongoing clinic staff input to enhance trial success and optimize clinic workflow. Results: Using the strategies mentioned above, Hawai’i M/U NCORP was able to successfully open and enroll to an internet based CCDR implantation trial at a community clinic from 2019 through 2021. Not only were we able to achieve the highest accrual to a CCDR implementation trial to date within our NCORP, but also managed to do so at a clinic that had previously had minimal involvement in clinical trials in the past. Providers within the clinic received very positive reviews from their patients regarding the trial elements and the clinic has been working toward continuing the use of the material introduced by this CCDR implantation trial. Conclusions: Our successful use of these strategies described have not only been beneficial for our NCORP, but has made a large impact on improving the quality of clinic care at a busy community site. Our involved multi-step opening strategies set the stage for a seamless clinic workflow throughout the trial. This research has proven that these strategies can lead to the success of CCDR implementation studies in a community practice.
    Type of Medium: Online Resource
    ISSN: 0732-183X , 1527-7755
    URL: Article
    DOI: 10.1200/JCO.2022.40.16_suppl.e13525
    RVK:
    XA 52760
    RVK:
    XA 10000
    Language: English
    Publisher: American Society of Clinical Oncology (ASCO)
    Publication Date: 2022
    detail.hit.zdb_id: 2005181-5
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Open Access Request
    Availability (electronic / print)
  • 4
    Online Resource
    Online Resource
    Role of oncology-advanced practitioners to enhance clinical research.
    American Society of Clinical Oncology (ASCO) ; 2020
    In:  Journal of Clinical Oncology Vol. 38, No. 29_suppl ( 2020-10-10), p. 95-95
    Details
    In: Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 38, No. 29_suppl ( 2020-10-10), p. 95-95
    Abstract: 95 Background: Oncology Advanced Practitioners (APs), including Nurse Practitioners, Physician Assistants, Clinical Nurse Specialists, and Pharmacists are highly trained health care providers that contribute significantly to quality cancer care. Given low clinical trial enrollment among adult oncology patients, understanding current research responsibilities of APs could lead to identification of opportunities to leverage this workforce to enhance accrual and conduct of clinical trials. Methods: A 65-item validated survey addressing attitudes, beliefs and responsibilities of oncology APs participating in clinical research was distributed from January 22 through March 6, 2020. Outreach via the Association of Community Cancer Centers (ACCC) and Harborside was utilized to reach a sample set of 14,601 oncology APs’ emails. The survey was administered and data were analyzed using Survey Monkey. Results: 408 U.S. oncology APs completed the survey. Respondents were primarily white (83%), female (92%) and nurse practitioners (71%). Thirty-five percent practiced in an academic setting and 62% practiced in a community setting. Nearly all respondents believed that clinical trials are important to improve oncology care standards and more than 90% reported that clinical trials were available at their practice. Nearly 80% reported that they are comfortable discussing treatment options with patients, discussing clinical trials in general, and know where to find clinical trials. Furthermore, 80% participate in the care of patients enrolled on clinical trials. Only 60%, however, are comfortable discussing trials available at their practice and only 38% routinely explore whether a clinical trial is available for their patients. While 70% of APs approach eligible patients about clinical trials at their practice, only 20% reported doing so “a great deal” or “a lot”. Ninety percent of APs reported that they should play a role in clinical research and 75% would like to be more involved in the clinical trial process. Barriers to greater involvement in clinical trials include lack of time, inadequate awareness of clinical trial specifics, and under-representation on research committees. Conclusions: The majority of oncology APs are engaged and interested in clinical trials and believe that research is important to improve cancer care. However, they are not being utilized to their full scope. Multidisciplinary team integration, trials-related education, and policy change is needed to allow this group of skilled professionals to realize their full potential within cancer clinical trials.
    Type of Medium: Online Resource
    ISSN: 0732-183X , 1527-7755
    URL: Article
    DOI: 10.1200/JCO.2020.38.29_suppl.95
    RVK:
    XA 52760
    RVK:
    XA 10000
    Language: English
    Publisher: American Society of Clinical Oncology (ASCO)
    Publication Date: 2020
    detail.hit.zdb_id: 2005181-5
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Open Access Request
    Availability (electronic / print)
  • 5
    Online Resource
    Online Resource
    The AP Role in Clinical Research: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner
    Harborside Press, LLC ; 2022
    In:  Journal of the Advanced Practitioner in Oncology Vol. 13, No. 6 ( 2022-8-1), p. 633-636
    Details
    In: Journal of the Advanced Practitioner in Oncology, Harborside Press, LLC, Vol. 13, No. 6 ( 2022-8-1), p. 633-636
    Abstract: Elizabeth Koselke, PharmD, BCOP, of The US Oncology Network, describes a clinical pharmacist intervention to screen patients and improve clinical trial enrollment. Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP®, of the University of Hawai‘i Cancer Center, details a team approach to both increase clinical trial accrual and improve clinical trial conduct.
    Type of Medium: Online Resource
    ISSN: 2150-0878
    URL: Issue
    URL: Journal
    URL: Article
    DOI: 10.6004/jadpro.2022.13.6
    DOI: 10.6004/jadpro
    DOI: 10.6004/jadpro.2022.13.6.10
    Language: Unknown
    Publisher: Harborside Press, LLC
    Publication Date: 2022
    detail.hit.zdb_id: 3022897-9
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Open Access Request
    Availability (electronic / print)
  • 6
    Online Resource
    Online Resource
    Understanding Attitudes and Roles of Oncology Advanced Practitioners in the Setting of Cancer Clinical Trials: A Pilot Study
    Harborside Press, LLC ; 2021
    In:  Journal of the Advanced Practitioner in Oncology Vol. 12, No. 5 ( 2021-7-1)
    Details
    In: Journal of the Advanced Practitioner in Oncology, Harborside Press, LLC, Vol. 12, No. 5 ( 2021-7-1)
    Abstract: Purpose: Oncology advanced practitioners (APs), including nurse practitioners, physician assistants, clinical nurse specialists, and pharmacists, are skilled health-care providers who contribute significantly to quality cancer care. However, little is known about how APs function within the clinical trials arena. With low rates of clinical trial enrollment among the adult oncology patient population, APs could play an important role in improving clinical trial enrollment. Methods: A descriptive cross-sectional study was conducted based on a 57-item survey of oncology APs’ attitudes, beliefs, and roles in relation to cancer clinical trials. Results: To assess validity and internal consistency of the survey, a pilot data collection was completed on 14 respondents from Hawaii. The survey’s internal consistency across the subscales was moderate to very high, with Cronbach’s alpha ranging between 0.55 and 0.86. The majority of oncology APs were interested in being more involved in the clinical trials process, and many are registered as investigators through the National Cancer Institute (NCI). However, few respondents reported being involved in recruitment, consenting, protocol development, or being actively involved with a research base. Conclusions: This survey was found to be a valid tool to measure APs’ attitudes and roles in regards to clinical trials. This survey is just the beginning of data collection in regards to clinical trials among this group of health-care professionals. Recommendations: To gain further insight into oncology APs and their roles in clinical trials, it is recommended that this survey be implemented on a national level as a first step in moving this issue forward.
    Type of Medium: Online Resource
    ISSN: 2150-0878
    URL: Issue
    URL: Journal
    URL: Article
    DOI: 10.6004/jadpro.2021.12.5
    DOI: 10.6004/jadpro
    DOI: 10.6004/jadpro.2021.12.5.2
    Language: Unknown
    Publisher: Harborside Press, LLC
    Publication Date: 2021
    detail.hit.zdb_id: 3022897-9
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Open Access Request
    Availability (electronic / print)
  • 7
    Online Resource
    Online Resource
    Role of Oncology Advanced Practitioners to Enhance Clinical Research
    Harborside Press, LLC ; 2022
    In:  Journal of the Advanced Practitioner in Oncology Vol. 13, No. 2 ( 2022-3-1), p. 107-119
    Details
    In: Journal of the Advanced Practitioner in Oncology, Harborside Press, LLC, Vol. 13, No. 2 ( 2022-3-1), p. 107-119
    Abstract: Background: Oncology advanced practitioners (APs), including nurse practitioners, clinical nurse specialists, physician assistants, and clinical pharmacists contribute significantly to quality cancer care. Advanced practitioners enhance value across the spectrum of cancer care. Research is an underdeveloped component of quality care, as well as an underdeveloped component of AP practice. Understanding research-related attitudes and roles of APs could lead to enhanced clinical trial accrual, conduct, and protocol development. Methods: A nationwide survey addressing attitudes, beliefs, and roles of APs regarding clinical research was distributed by the Association of Community Cancer Centers (ACCC) and Harborside in early 2020. Results: 408 oncology APs completed the survey. Thirty-five percent practice in an academic setting and 62% in the community. Nearly all respondents believe clinical trials are important to improve care, and over 90% report clinical trials are available at their practice. About 80% report being comfortable discussing the topic of clinical trials with patients and are involved in the care of trial participants. Sixty percent are comfortable discussing available trials, and 38% routinely explore available trials with patients. While 70% report approaching eligible patients about trials, only 20% report doing so “a great deal” or “a lot.” Ninety percent report that APs should play a role in clinical research, and 73% want to be more involved. Barriers identified to greater AP clinical trial involvement include lack of time, inadequate awareness of trial specifics, and a lack of a formal role in protocol development and leadership. Conclusions: Advanced practitioners are engaged and interested in clinical trials and believe clinical research is important to improve cancer care. Multidisciplinary team integration, trials-related education, and policy change are needed to employ APs to their full potential within cancer clinical trials.
    Type of Medium: Online Resource
    ISSN: 2150-0878
    URL: Issue
    URL: Journal
    URL: Article
    DOI: 10.6004/jadpro.2022.13.2
    DOI: 10.6004/jadpro
    DOI: 10.6004/jadpro.2022.13.2.2
    Language: Unknown
    Publisher: Harborside Press, LLC
    Publication Date: 2022
    detail.hit.zdb_id: 3022897-9
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Open Access Request
    Availability (electronic / print)
  • 8
    Online Resource
    Online Resource
    Racial Disparities in Patient-Provider Communication During Telehealth Visits Versus Face-to-face Visits Among Asian and Native Hawaiian and Other Pacific Islander Patients With Cancer: Cross-sectional Analysis
    JMIR Publications Inc. ; 2022
    In:  JMIR Cancer Vol. 8, No. 4 ( 2022-12-9), p. e37272-
    Details
    In: JMIR Cancer, JMIR Publications Inc., Vol. 8, No. 4 ( 2022-12-9), p. e37272-
    Abstract: Telehealth visits increase patients’ access to care and are often rated as “just as good” as face-to-face visits by oncology patients. Telehealth visits have become increasingly more common in the care of patients with cancer since the advent of the COVID-19 pandemic. Asians and Pacific Islanders are two of the fastest growing racial groups in the United States, but there are few studies assessing patient satisfaction with telemedicine among these two racial groups. Objective Our objective was to compare satisfaction with communication during telehealth visits versus face-to-face visits among oncology patients, with a specific focus on Asian patients and Native Hawaiian and other Pacific Islander (NHOPI) patients. Methods We surveyed a racially diverse group of patients who were treated at community cancer centers in Hawaii and had recently experienced a face-to-face visit or telehealth visit. Questions for assessing satisfaction with patient-physician communication were adapted from a previously published study of cancer survivors. Variables that impact communication, including age, sex, household income, education level, and cancer type and stage, were captured. Multivariable logistic models for patient satisfaction were created, with adjustments for sociodemographic factors. Results Participants who attended a face-to-face visit reported higher levels of satisfaction in all communication measures than those reported by participants who underwent a telehealth encounter. The univariate analysis revealed lower levels of satisfaction during telehealth visits among Asian participants and NHOPI participants compared to those among White participants for all measures of communication (eg, when asked to what degree “[y]our physician listened carefully to you”). Asian patients and NHOPI patients were significantly less likely than White patients to strongly agree with the statement (P 〈 .004 and P 〈 .007, respectively). Racial differences in satisfaction with communication persisted in the multivariate analysis even after adjusting for sociodemographic factors. There were no significant racial differences in communication during face-to-face visits. Conclusions Asian patients and NHOPI patients were significantly less content with patient-physician communication during telehealth visits when compared to White patients. This difference among racial groups was not seen in face-to-face visits. The observation that telehealth increases racial disparities in health care satisfaction should prompt further exploration.
    Type of Medium: Online Resource
    ISSN: 2369-1999
    URL: Article
    DOI: 10.2196/37272
    Language: English
    Publisher: JMIR Publications Inc.
    Publication Date: 2022
    detail.hit.zdb_id: 2928105-2
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Open Access Request
    Availability (electronic / print)
  • 9
    Online Resource
    Online Resource
    Enrolling Older Adults Onto National Cancer Institute–Funded Clinical Trials in Community Oncology Clinics: Barriers and Solutions
    Oxford University Press (OUP) ; 2022
    In:  JNCI Monographs Vol. 2022, No. 60 ( 2022-12-15), p. 117-124
    Details
    In: JNCI Monographs, Oxford University Press (OUP), Vol. 2022, No. 60 ( 2022-12-15), p. 117-124
    Abstract: In April 2021, the National Cancer Institute (NCI) Division of Cancer Prevention collaborated with the NCI Division of Cancer Treatment and Diagnosis to produce a virtual workshop that developed recommendations for enhancing NCI-sponsored clinical trial accrual of older adults. Prior to the workshop, a multidisciplinary group of stakeholders (eg, community oncologists, advanced practice practitioners, clinic and research staff, and patient advocates) gathered information related to accrual of older adults to clinical trials from the literature. Subsequently, a survey was conducted to detail NCI Community Oncology Research Program members’ perspective on accrual barriers for this population; 305 individuals responded to the survey. Barriers to clinical trial accruals included comorbidity-attributed trial ineligibility, transportation and time issues, concern that the proposed regimen is too toxic for older adults, patient or family caregiver declined participation, and lack of trials relevant to older patients. Identified solutions included broadening clinical trial inclusion criteria, increasing the number of clinical trials specifically designed for older adults, simplifying consent forms, improving recruitment materials for older adults and their families, and facilitating transportation vouchers. At the workshop, participants, including stakeholders, used prior literature and survey results to develop recommendations, including interventions to address clinician bias, implement geriatric assessment, and promote clinician and staff engagement as mechanisms to improve accrual of older adults to clinical trials.
    Type of Medium: Online Resource
    ISSN: 1052-6773 , 1745-6614
    URL: Article
    DOI: 10.1093/jncimonographs/lgac019
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2022
    detail.hit.zdb_id: 2044141-1
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Open Access Request
    Availability (electronic / print)
  • 10
    Online Resource
    Online Resource
    Through the Lens of Patient Partners: Challenges in Accrual of Older Adults to NCI Clinical Trials
    Oxford University Press (OUP) ; 2022
    In:  JNCI Monographs Vol. 2022, No. 60 ( 2022-12-15), p. 125-134
    Details
    In: JNCI Monographs, Oxford University Press (OUP), Vol. 2022, No. 60 ( 2022-12-15), p. 125-134
    Abstract: The workshop “Engaging Older Adults in Cancer Clinical Trials Conducted in the NCI Clinical Trials Network: Challenges and Opportunities” included a Patient Stakeholder Workgroup that explored the needs and concerns of older adults with cancer regarding clinical trials. To accomplish this, the workgroup conducted patient focus groups in which participants were interviewed, recorded conversations were analyzed and coded, and salient themes were identified. The focus groups identified general barriers to accrual such as complex consent forms, general communication, restrictive eligibility, nonreferrals, patient costs, cultural insensitivity, limited accessibility in community settings, and transportation issues. They also identified the influence of knowledgeable information presenters, improved care, family or caregiver support, and the desire to help others as drivers or reasons to participate in clinical trials. The workshop concluded that multi-level interventions could be used to increase the accrual of older adults to National Cancer Institute clinical trials as well as others.
    Type of Medium: Online Resource
    ISSN: 1052-6773 , 1745-6614
    URL: Article
    DOI: 10.1093/jncimonographs/lgac022
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2022
    detail.hit.zdb_id: 2044141-1
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Open Access Request
    Availability (electronic / print)
Nothing or not found what you are looking for? Please check your search query or use the Interlibrary Loan Search.
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages